| [1] |
Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome[J]. Clin Epidemiol, 2014(6):99-109.
|
| [2] |
Creasy JM, Goldman DA, Gonen M, et al. Evolution of surgical management of gallbladder carcinoma and impact on outcome: results from two decades at a single-institution[J]. HPB, 2019, 21(11):1541-1551.
|
| [3] |
Rawla P, Sunkara T, Thandra KC, et al. Epidemiology of gallbladder cancer[J]. Clin Exp Hepatol, 2019, 5(2):93-102.
|
| [4] |
Govil S, Reddy MS, Rela M. Surgical resection techniques for locally advanced hilar cholangiocarcinoma[J]. Langenbecks Arch Surg, 2014, 399(6):707-716.
|
| [5] |
Kendall T, Verheij J, Gaudio E, et al. Anatomical, histomorphological and molecular classification of cholangiocarcinoma[J]. Liver Int, 2019, 39 Suppl 1:7-18.
|
| [6] |
中华医学会外科学分会胆道外科学组，中国医师协会外科医师分会胆道外科专业委员会．胆囊癌诊断和治疗指南(2019版)[J]. 中华外科杂志, 2020, 58(4):243-251．
|
| [7] |
汤朝晖, 杨勇, 刘颖斌, 等. 第7版胆囊癌TNM分期(AJCC)解读与思考[J]. 中国实用外科杂志, 2010, 30(5):366-371.
|
| [8] |
Fong Y, Wagman L, Gonen M, et al. Evidence-based gallbladder cancer staging: changing cancer staging by analysis of data from the National Cancer Database[J]. Ann Surg, 2006, 243(6):767-771.
|
| [9] |
梁廷波, 白雪莉. 胆囊癌分期临床意义及评价[J]. 中国实用外科杂志, 2011, 31(3):194-197.
|
| [10] |
汤朝晖, 刘颖斌, 全志伟. 肿瘤分期对胆囊癌术式选择及预后判断临床意义研究[J]. 中国实用外科杂志, 2011, 31(3):224-227.
|
| [11] |
Edge SB, Byrd DR, Compton CC, et al. AJCC cancer staging manual[M]. 7th ed. New York: Springer, 2010.
|
| [12] |
汤朝晖, 庄鹏远, 杨勇, 等. 胆囊癌AJCC第7版分期要点解读及规范应用[J]. 中国实用外科杂志, 2011, 31(3):221-223.
|
| [13] |
Mahul BA, Stephen E, Frederick LG, et al. AJCC cancer staging manual[M]. 8th ed. New York: Springer, 2016.
|
| [14] |
汤朝晖, 田孝东, 魏妙艳, 等. 美国癌症联合委员会胆道恶性肿瘤分期系统(第8版)更新解读[J]. 中国实用外科杂志, 2017, 37(3):248-254.
|
| [15] |
Shindoh J, de Aretxabala X, Aloia TA, et al. Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study[J]. Ann Surg, 2015, 261(4): 733-739.
|
| [16] |
Lamarca A, Edeline J, Mcnamara MG, et al. Current standards and future perspectives in adjuvant treatment for biliary tract cancers[J]. Cancer Treat Rev, 2020(84):101936.
|
| [17] |
Tella SH, Kommalapati A, Borad MJ, et al. Second-line therapies in advanced biliary tract cancers[J]. Lancet Oncol, 2020, 21(1):e29-41.
|
| [18] |
Miyazaki M, Itoh H, Ambiru S, et al. Radical surgery for advanced gallbladder carcinoma[J]. Br J Surg, 1996, 83(4):478-481.
|
| [19] |
Kondo S, Nimura Y, Kamiya J, et al. Mode of tumor spread and surgical strategy in gallbladder carcinoma[J]. Langenbecks Arch Surg, 2002, 387(5/6):222-228.
|
| [20] |
张东, 耿智敏, 陈晨, 等. 胆囊癌的临床分型和预后关系初步分析:多中心回顾性临床研究[J]. 中华外科杂志, 2019, 57(4):258-264.
|
| [21] |
Fong Y, Jarnagin W, Blumgart LH. Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention[J]. Ann Surg, 2000, 232(4):557-569.
|
| [22] |
Hueman MT, Vollmer CM Jr, Pawlik TM. Evolving treatment strategies for gallbladder cancer[J]. Ann Surg Oncol, 2009, 16(8): 2101-2115.
|
| [23] |
Wang L, Audenaert P, Michoel T. High-dimensional bayesian network inference from systems genetics data using genetic node ordering[J]. Front Genet, 2019(10):1196.
|
| [24] |
Kayahara M, Nagakawa T, Nakagawara H, et al. Prognostic factors for gallbladder cancer in Japan[J]. Ann Surg, 2008, 248(5):807-814.
|
| [25] |
Oven Ustaalioglu BB, Bilici A, Seker M, et al. Prognostic factors for operated gallbladder cancer[J]. J Gastrointest Cancer, 2019, 50(3): 451-457.
|
| [26] |
Lee W, Jeong CY, Jang JY, et al. Do hepatic-sided tumors require more extensive resection than peritoneal-sided tumors in patients with T2 gallbladder cancer? results of a retrospective multicenter study[J]. Surgery, 2017, 162(3):515-524.
|
| [27] |
朱振成, 罗昆仑, 伍斌, 等. 不同解剖位置胆囊癌患者手术治疗的预后因素分析[J]. 中华肝胆外科杂志, 2020, 26(8):600-605.
|
| [28] |
刘颖斌, 刘付宝, 彭淑牖. 胆囊癌扩大根治术范围、术式选择及评价[J]. 实用肿瘤杂志, 2005, 20(1):14-16.
|
| [29] |
王建承, 费健, 蒋渝, 等. 原发性胆囊癌的预后与病理和手术类型的关系[J]. 中华普通外科杂志, 2001(2):85-87.
|
| [30] |
俞文隆, 杨晓宇, 张永杰. 胆囊癌扩大根治性切除术的范围与术式选择[J]. 中国实用外科杂志, 2011(3):209-212.
|
| [31] |
Krell RW, Wei AC. Gallbladder cancer: surgical management[J]. Chin Clin Oncol, 2019, 8(4):36.
|
| [32] |
Duffy A, Capanu M, Abou-Alfa GK, et al. Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC)[J]. J Surg Oncol, 2008, 98(7):485-489.
|
| [33] |
Nepal C, Zhu B, O'Rourke CJ, et al. Integrative molecular characterisation of gallbladder cancer reveals micro-environment-associated subtypes[J]. J Hepatol, 2021, 74(5):1132-1144.
|